Literature DB >> 25386815

Interaction between DNA/histone methyltransferases and their inhibitors.

J Hu, S Chen, X Kong, K Zhu, S Cheng, M Zheng, H Jiang, C Luo1.   

Abstract

Epigenetic research has recently become one of the hotspots in the field of bioscience and drug design. DNA methylation and histone methylation serve a critical function in influencing gene expression and genome function. The inhibition of DNA and histone methyltransferases (DNMTs and HMTs) is a promising approach for the therapeutic treatment of numerous diseases, including cancer. This work reviews the recent achievements in methyltransferase crystallographic structure resolution and bioactive inhibitor screening. We discuss the features of DNA and HMT structures, as well as the mechanism and structure-function relationship of transferase inhibitors, to elucidate how methyltransferase and inhibitor interactions occur both internally and externally. This study briefly reviews the biological function, as well as the inhibitor discovery and development, of DNA/histone methyltransferases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25386815     DOI: 10.2174/0929867321666141106114538

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  3 in total

Review 1.  Histone methyltransferases: novel targets for tumor and developmental defects.

Authors:  Xin Yi; Xue-Jun Jiang; Xiao-Yan Li; Ding-Sheng Jiang
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 2.  Dissecting bipolar disorder complexity through epigenomic approach.

Authors:  B Ludwig; Y Dwivedi
Journal:  Mol Psychiatry       Date:  2016-08-02       Impact factor: 15.992

3.  Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma.

Authors:  Yingying Miao; Guifeng Liu; Lin Liu
Journal:  Cancer Cell Int       Date:  2021-01-04       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.